KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Other Working Capital Changes (2016 - 2025)

Cvs Health (CVS) has disclosed Other Working Capital Changes for 17 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes rose 346.92% year-over-year to $2.0 billion, compared with a TTM value of $2.6 billion through Dec 2025, up 6723.68%, and an annual FY2025 reading of $2.6 billion, up 6723.68% over the prior year.
  • Other Working Capital Changes was $2.0 billion for Q4 2025 at Cvs Health, up from -$381.0 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.8 billion in Q1 2024 and bottomed at -$1.4 billion in Q3 2024.
  • Average Other Working Capital Changes over 5 years is $242.9 million, with a median of -$52.0 million recorded in 2022.
  • The sharpest move saw Other Working Capital Changes soared 390.59% in 2022, then tumbled 10050.0% in 2024.
  • Year by year, Other Working Capital Changes stood at -$85.0 million in 2021, then skyrocketed by 390.59% to $247.0 million in 2022, then crashed by 103.24% to -$8.0 million in 2023, then crashed by 10050.0% to -$812.0 million in 2024, then soared by 346.92% to $2.0 billion in 2025.
  • Business Quant data shows Other Working Capital Changes for CVS at $2.0 billion in Q4 2025, -$381.0 million in Q3 2025, and -$132.0 million in Q2 2025.